Shionogi Europe B.V.
Acronym: SBV
General Information
Identification Code: 375242047294-04
Website: www.shionogi.com
Entity Form: European Headquarters of Shionogi & Co. Ltd
Registration Category: Companies & groups
Registration Date: 8/4/2022
Last Update: 7/10/2023
Mission & Interests
Goals: Shionogi Europe is the European Headquarters of the global pharmaceutical company Shionogi & Co Ltd based in Osaka, Japan. The company has been researching and developing pharmaceutical products for over 140 years and has a particular expertise in infectious diseases.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Public health
- Research and innovation
Levels of Interest:
- european
Activities
Main EU Legislative Proposals: General health strategy
Revised pharma legislation
Other policies to be targeted will be identified in the next two months
Communication Activities: Gastein 2023 - AMR debate Race Against Resistance
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: 1-8, Doshomachi 3-chomeChuo-ku
City: Osaka
Country: JAPAN
Phone:
Indic Phone: 81
Phone Number: 662022161
EU Office
Address: Herengracht 4641017 CA
City: Amsterdam
Country: NETHERLANDS
Phone:
Indic Phone: 44
Phone Number: 02030534200
Financial Data
Closed Year:
Start Date:
End Date:
Funding Sources:
Contributions:
Total Budget: 0
Grants:
Current Year:
Grants:
Complementary Information: Shionogi has not historically conducted lobbying activities as an organisation itself or through an intemediary. It is a member of EUCOPE and as such has participated in regulatory policy submissions and events
Membership Information
Members25 Percent: 1
Members: 1
Members F T E: 0.25
Structure
Structure Type: Structure
Is Member Of: None so far
Organisation Members: European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
Current Job Opportunities
Graduate Intern in EU Public Health Policy
Shionogi Europe B.V.
internBrussels, BelgiumFull-time-time
Posted: 9/23/2025
mid-levelBrussels, Francefull-time
Posted: 8/21/2025